Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia

Leukemia

Volumn 22, Issue 6, 2008, Pages 1256-1257

  Ball, L ^a   Bredius, R ^a   Lankester, A ^a   Schweizer, J ^a   van den Heuvel Eibrink, M ^b   Escher, H ^b   Fibbe, W ^a   Egeler, M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MELPHALAN; MESNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROBENECID; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADENOVIRUS; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; DIARRHEA; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; GRAFT VERSUS HOST REACTION; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INTESTINAL FIBROSIS; JUVENILE MYELOMONOCYTIC LEUKEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELL TRANSPLANTATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR; TREATMENT FAILURE; VARIABLE NUMBER OF TANDEM REPEAT; VIRUS INFECTION;

EID: 45149085724     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405013     Document Type: Article

References (7)

1. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
2. Ringden O, Uzunel M, Sundberg B, Lönnies L, Nava S, Gustafsson J et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007 July 5; [E-pub ahead of print]. doi: 10.1038/ sj.leu.2404833.
3. Couriel A, Caldera H, Champlin R, Komanduri K. Acute graft versus host disease: Pathophysiology, clinical manifestations, and management. Cancer 2004; 101: 1936-1946.
4. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR et al. A retrospective analysis of severe acute graft-versus-host disease. Blood 1990; 76: 1464-1472.
5. Le Blanc K, Frassoni F, Ball LM, Uzñel M, Lanini E, Sundberg B et al. Mesenchymal stem cells for treatment of severe acute graft-versus-h st disease. Blood 2006; 180: 226a (abstract 753).
6. Nauta A, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, (2007-02-0697) 16, July 30; [E-pub ahead of print].
7. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 2003; 100 (Suppl 1): 11917-11923.